Portal:CPTAC/FeaturedPathways
From WikiPathways
(Difference between revisions)
(Adding WP4216) |
(Added two CRC pathways) |
||
| Line 19: | Line 19: | ||
|width=100px|{{#pwImage:Pathway:WP4206|250px||Hereditary Leiomyomatosis and Renal Cell Carcinoma Pathway}} | |width=100px|{{#pwImage:Pathway:WP4206|250px||Hereditary Leiomyomatosis and Renal Cell Carcinoma Pathway}} | ||
|width=100px|{{#pwImage:Pathway:WP4216|250px||Chromosomal and microsatellite instability in colorectal cancer}} | |width=100px|{{#pwImage:Pathway:WP4216|250px||Chromosomal and microsatellite instability in colorectal cancer}} | ||
| + | |width=100px|{{#pwImage:Pathway:WP4239|250px||EMT transition in Colorectal Cancer}} | ||
| + | |width=100px|{{#pwImage:Pathway:WP4240|250px||Regulation of sister chromatid separation at the metaphase-anaphase transition}} | ||
|} | |} | ||
Revision as of 17:25, 23 March 2018
|
Image does not exist TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer |
Image does not exist PDGFR-beta pathway Zhang, et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer |
Image does not exist Bladder Cancer |
Image does not exist EPO Receptor Signaling |
|
Image does not exist ErbB Signaling Pathway |
Image does not exist Interferon type I signaling pathways |
Image does not exist Transcriptional activation by NRF2 |
Image does not exist Pathways in clear cell renal cell carcinoma |
|
Image does not exist MFAP5-mediated ovarian cancer cell motility and invasiveness |
Image does not exist Endometrial cancer |
Image does not exist Tumor suppressor activity of SMARCB1 |
Image does not exist Type 1 Papillary renal Cell Carcinoma |
|
Image does not exist Hereditary Leiomyomatosis and Renal Cell Carcinoma Pathway |
Image does not exist Chromosomal and microsatellite instability in colorectal cancer |
Image does not exist EMT transition in Colorectal Cancer |
Image does not exist Regulation of sister chromatid separation at the metaphase-anaphase transition |
